EDC Comes of Age: Surviving the Transition from Paper-Based Data Capture to EDC

EDC Comes of Age: Surviving the Transition from Paper-Based Data Capture to EDC -- MBC Biostatistics & Data Management Committee

12/7/2007

You are invited to join the MBC Biostatistics and Data Management Committee for a presentation on "EDC Comes of Age: Surviving the Transition from Paper-Based Data Capture to EDC"

When: Friday December 7, 2007 Time: 12:00-2:00 PM Where: MBC Office, One Cambridge Center, 9th Floor, Cambridge, MA

Topic: EDC Comes of Age: Surviving the Transition from Paper-Based Data Capture to EDC

Like it or not, EDC is here to stay. Getting faster results and seeing data trends has an immediate impact on a company's bottom line. Over the last 10 years, companies have made a transition away from paper-based data capture to electronic data capture (EDC). EDC also changes how clinical data managers, project managers and CRAs work together. In this panel discussion, presenters from Boston Scientific and Vertex Pharmaceuticals will describe their experiences of rolling out EDC within their organizations, and how EDC has changed traditional roles and the corporate culture. If you are considering EDC for your next clinical programs, or are waist-deep in managing the transition, please join us for an informative and lively discussion.

Speakers:

Teresa Ancukiewicz, Senior Manager, Boston Scientific Corporation.

Alison Osattin, Clinical Program Manager, Boston Scientific Corporation

Molly Aalyson, Associate Director, Clinical Programs, Vertex Pharmaceuticals, Inc.

Stacy Surensky, Associate Director, Clinical Data Management, Vertex Pharmaceuticals, Inc.

Moderator: Elizabeth Merica, BioBridges, Inc.